Top 10 Blockbuster Drugs Facing U.S. Patent Expirations (2025–2029)
8 September 2025 Category: Drug DevelopmentFor pharma leaders, investors, and business development teams, these five years represent both risk and opportunity on a historic scale.
Blog
9 Pharma Giants Leading the Monoclonal Antibody with FY24-25 Revenue
23 August 2025 Category: Drug DevelopmentCompanies have realized the era of innovation and advance drug developments is around the corner. One of the key areas that is witnessing a surge is monoclonal antibodies.
15 Biologics are Going off Patent (2025–2029)
12 June 2025 Category: Drug DevelopmentGlobal biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
Applying Complex Innovative Clinical Trial Designs to Orphan Drug Development
30 April 2025 Category: Drug DevelopmentThe design and development of orphan drugs, designed for rare diseases, are uniquely challenged as limited patient populations available for clinical trials.
Harnessing Continuous Data to Advance Clinical Discovery
21 January 2025 Category: Drug DevelopmentHarnessing continuous data to accelerate clinical discovery, driving innovation with real-time insights and transformative solutions for healthcare breakthroughs.
Latest Blogs
-
How to Prevent API Shortages Using..
23 June 2026
-
The New Era of Rare Disease Drug De..
17 June 2026
-
Why Every Pharma Company Needs a Un..
8 June 2026
-
How Early-Phase Pipeline Tracking C..
2 June 2026
-
The Rise of First in Class Drugs: W..
27 May 2026
